Immunogenicities of HBV DNA and Recombinant Modified Vaccinia Ankara-based HB Vaccines

陈宇,杨小松,杨萍,张帆,于湘晖,吴永革,姜春来,李惟,孔维
DOI: https://doi.org/10.3969/j.issn.1004-5503.2007.09.008
2007-01-01
Abstract:Objective To compare the immunogenicities of HBV DNA and recombinant modified vaccina Ankara(rMVA)-based HB vaccines.Methods Immunize BALB/c mice with rMVA-based HB vaccine and HBV DNA vaccine respectively,then determine the humoral immune response by ELISA,and cellular immune response by ELISPOT.Results The serum HB antibody levels of mice immunized with rMVA-based HB vaccine and HBV DNA vaccine were 135 and 104 mIU/ml,and the numbers of spot-forming cells(SFC) were 550 and 314 cells per 106 lymphocytes respectively.Conclusion rMVA-based HB vaccine was more immunogenic than HBV DNA vaccine.
What problem does this paper attempt to address?